About Bionexus Gene Lab
Bionexus Gene Lab is a publicly listed company based in Sheridan (United States) founded in 2017. Blood-based genomic screening services are provided by the laboratory. The company has 30 employees. Its focus areas include Medical Research Labs.
Company details
Bionexus Gene Lab was established in 2017 in Sheridan, United States. Services in blood-based genomic screening (BGS) are offered within the biotechnology sector. Operations are centered on laboratory-based testing for genomic analysis using blood samples. The company maintains its domain at bionexusgenelab.com, with activities focused on diagnostic screening processes in a regulated environment.
- Headquarters Sheridan, United States
- Employees 30
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bionexusgenelab.com
- Legal Name Bionexus Gene Lab Corp
- Annual Revenue$7.42 M (USD)-21.93as on Dec 31, 2025
- Net Profit-$2.98 M (USD)-86.73as on Dec 31, 2025
- EBITDA-$2.99 M (USD)-65.79as on Dec 31, 2025
- Employee Count30
IPO & Listings of Bionexus Gene Lab
Bionexus Gene Lab is a publicly listed company on the NASDAQ with ticker symbol BGLC in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Sep 2020
- Listed onNASDAQ: BGLC
- Listed entityBioNexus Gene Lab Corp
- Exchange sectorDistribution services
- ISINUS0906283066
- Share price$1.32 (-5.01% on the day) · 2026-10-13
- Market capitalisation$3.9M
- EPS (diluted, trailing year)$-1.26
- Volume (last session)8,387
Financials of Bionexus Gene Lab
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $7.4M | -$3.0M | -$3.0M |
| 2024 | $9.5M | -$1.6M | -$1.8M |
| 2023 | $9.8M | -$2.6M | -$3.0M |
| 2022 | $10.9M | -$355,970 | -$365,040 |
| 2021 | $13.4M | $751,570 | $1.1M |
Detailed financial statements for Bionexus Gene Lab
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Bionexus Gene Lab (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bionexus Gene Lab
Complete news archive for Bionexus Gene Lab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bionexus Gene Lab
Bionexus Gene Lab was founded in 2017.
Bionexus Gene Lab is headquartered in Sheridan, United States. It is registered at Sheridan, Wyoming, United States.
Bionexus Gene Lab has 30 employees.
Annual revenue of Bionexus Gene Lab is $7.42M as on Dec 31, 2025.
Bionexus Gene Lab was established in 2017 in Sheridan, United States. Services in blood-based genomic screening (BGS) are offered within the biotechnology sector. Operations are centered on laboratory-based testing for genomic analysis using blood samples. The company maintains its domain at bionexusgenelab.com, with activities focused on diagnostic screening processes in a regulated environment.
Yes, Bionexus Gene Lab is publicly traded on NASDAQ under the ticker symbol BGLC.